ERVW-1 and HIV-1 infection: Given the large number of bnAbs now available against multiple epitope regions of HIV-1 Env, it is of great interest to have experimental measures and predictive models that can be used for evaluating and selecting optimal combinations of bnAbs for clinical development for the prevention and/or treatment of HIV-1 infection.